ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs

June 20, 1975

First “Annual” CCOP RFA Issued; Research Bases Must Compete

June 8, 1990

National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors

March 6, 1992

NIH Study Sections Use New Scoring Procedure

July 3, 1998